Canada markets closed

Dermata Therapeutics, Inc. (DRMAW)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.0081-0.0002 (-2.41%)
At close: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
0
0
0
0
0
-
Operating Expenses
Research Development
4,478
4,070
5,651
3,459
1,608
-
Selling General and Administrative
4,490
3,972
4,023
4,398
1,565
-
Total Operating Expenses
8,968
8,042
9,674
7,857
3,173
-
Operating Income or Loss
-8,968
-8,042
-9,674
-7,857
-3,173
-
Interest Expense
-
-
-63.573
45.613
197.269
250.748
Total Other Income/Expenses Net
-
-
-
-
133.592
-
Income Before Tax
-8,689
-7,795
-9,611
-7,902
-3,237
-
Income from Continuing Operations
-8,689
-7,795
-9,611
-7,902
-3,237
-
Net Income
-8,689
-7,795
-9,611
-7,902
-3,237
-
Net Income available to common shareholders
-8,689
-7,795
-9,611
-10,465
-3,237
-